Kolokotronis A, Doumas S
Dental School, Aristotle University of Thessaloniki, Oral Medicine/Pathology, Thessaloniki, Greece.
Clin Microbiol Infect. 2006 Mar;12(3):202-11. doi: 10.1111/j.1469-0691.2005.01336.x.
Primary herpetic gingivostomatitis (PHGS) represents the clinically apparent pattern of primary herpes simplex virus (HSV) infection, since the vast majority of other primary infections are symptomless. PHGS is caused predominantly by HSV-1 and affects mainly children. Prodromal symptoms, such as fever, anorexia, irritability, malaise and headache, may occur in advance of disease. The disease presents as numerous pin-head vesicles, which rupture rapidly to form painful irregular ulcerations covered by yellow-grey membranes. Sub-mandibular lymphadenitis, halitosis and refusal to drink are usual concomitant findings. Following resolution of the lesions, the virus travels through the nerve endings to the nerve cells serving the affected area, whereupon it enters a latent state. When the host becomes stressed, the virus replicates and migrates in skin, mucosae and, in rare instances, the central nervous system. A range of morbidities, or even mortality, may then occur, i.e., recurrent HSV infections, which are directly or indirectly associated with PHGS. These pathological entities range from the innocuous herpes labialis to life-threatening meningoencephalitis.
原发性疱疹性龈口炎(PHGS)是原发性单纯疱疹病毒(HSV)感染的临床明显表现形式,因为绝大多数其他原发性感染是无症状的。PHGS主要由HSV - 1引起,主要影响儿童。前驱症状,如发热、厌食、易怒、不适和头痛,可能在疾病发作前出现。该病表现为大量针头大小的水疱,水疱迅速破裂形成疼痛的不规则溃疡,表面覆盖有黄灰色膜。颌下淋巴结炎、口臭和拒饮是常见的伴随症状。病变消退后,病毒通过神经末梢传播到服务于受影响区域的神经细胞,随后进入潜伏状态。当宿主受到压力时,病毒会复制并迁移到皮肤、黏膜,在极少数情况下会迁移到中枢神经系统。然后可能会发生一系列疾病,甚至死亡,即与PHGS直接或间接相关的复发性HSV感染。这些病理实体范围从无害的唇疱疹到危及生命的脑膜脑炎。
Compend Contin Educ Dent. 2002-7
Quintessence Int. 2003-6
J Oral Pathol Med. 2008-2
Clin Case Rep. 2022-8-3
J Oral Pathol Med. 1998-1
Eur Ann Allergy Clin Immunol. 2006-2
BMC Infect Dis. 2020-10-20
Molecules. 2023-11-22
Clin Oral Investig. 2023-11
Clin Oral Investig. 2023-11
Indian Dermatol Online J. 2022-9-21
Clin Case Rep. 2022-8-3
Immun Inflamm Dis. 2022-7